13 June 2023 | Tuesday | News
Clinical teams collaborate with all stakeholders to ensure medically necessary treatment for the best results
According to a recent report by the Centers for Disease Control and Prevention (CDC), 1 in 36 children in the U.S. is diagnosed with an autism spectrum disorder, or ASD, an increase from the 2018 estimate that found a prevalence of 1 in 44. Diagnosis typically occurs by age 4, with minority groups tending to be diagnosed later and less often.
“Our main goal is to facilitate meaningful and effective responses to treatment that generalize across all environments and improve the well-being of the individual and their support system”
Tweet this
Most experts agree early intervention creates the best opportunity to support healthy development and deliver benefits across the lifespan for individuals with ASD. The CDC reports that applied behavioral analysis, or ABA therapy, is the most widely accepted, evidence-based form of treatment used in clinical settings that "encourages desired behaviors and discourages undesired behaviors." ABA supports increased language and communication, improved social skills, and enhanced attention in individuals with ASD.
The growing recognition of ABA therapy's efficacy and positive outcomes has led to an increased demand for these services across various communities. However, the limited availability of qualified ABA therapists and professionals has resulted in a gap between the demand and supply of this essential treatment. A 2021 study of Trends in Geographic Access to Board Certified Behavior Analysts (BCBAs) led by Dr. Marissa Yingling found that despite the growth of the ABA industry, more than half of all counties in the U.S. lack a single BCBA.
This dearth of providers, coupled with administrative burdens imposed by funders of ABA treatment, including health plans, makes timely intervention with ABA less accessible for many families.
As part of a five-part clinical quality publication series, the latest report issued by ACES 2020, LLC (ACES), an autism treatment provider whose clinical model is grounded in proven outcomes, explores how the company's Center of Excellence (COE) framework has allowed the company to drive medically necessary treatment plans to avoid gaps in care and produce high-quality outcomes. Specifically, ACES' client-centric approach, including understanding the participant's ecosystem through comprehensive assessment bundles and high-touch coordination of care practices, allows the company to better navigate and overcome some of the referenced barriers to treatment.
"The increased demand for proven clinical outcomes in the ABA field requires providers to offer precise treatment plans that are authorized quickly by funders, so that individuals impacted by autism, their caretakers and their families can find relief through ABA therapies faster," Leah Felty, vice president of payor relations and program management for ACES, said.
Felty said ACES employs a systematic and proprietary approach to communicate quality individualized treatment plans, based on the ACES Center of Excellence framework of personalized assessments and data collection, the needs of the individual client and family, how many hours of treatment are needed, coordination of care needs, and their treatment history. ACES pays close attention to the client's support system. Participation of the individual and their family in the decision-making process of treatment is obtained through consultation and review of the plan.
"Providing clinicians with more insight into the holistic needs of the individual and their family leads to more effective treatment planning, tied directly to medical necessity criteria, promoting alignment for appropriate utilization of prescribed ABA treatment," Felty said. "ACES has spent years developing trusting relationships including alignment of medically necessary criterion with our payer partners, which means we're not negotiating back and forth with our partners in peer reviews or appeals in order to get the necessary treatment right away."
Felty added that treatment adherence to medically necessary treatment recommendations (e.g., level of services, treatment interventions, coordination of care) positively relates to improved treatment effectiveness and positive outcomes.
"Our main goal is to facilitate meaningful and effective responses to treatment that generalize across all environments and improve the well-being of the individual and their support system," Felty said.
Visit the ACES website, https://www.acesaba.com/increased-demand-for-aba/, to download a copy of the report, Increased Demand for Applied Behavior Analysis Therapy Highlights Need for Personalized Treatment Plans and Targeted Outcome Goals, the latest edition in a series of data-based reporting on the ACES Center of Excellence Index in the treatment of autism.
© 2024 Biopharma Boardroom. All Rights Reserved.